📹 Why does intestinal fibrosis remain such a major unmet need in IBD?
On 3 June, FIBROTARGET’s Bram Verstockt joins the Nordic Bioscience webinar on collagen remodelling and fibrosis looking at current challenges and new clinical insights.
Register here➡️ https://loom.ly/na2rE6A
📢Early detection should not be a privilege.
➡️In IBD, specific biomarkers have been identified that can support diagnosis and classification, help monitor disease activity, and inform the likelihood of responding to treatment.
👉Learn more: https://loom.ly/Whlbs78
#AccessToCare #IBDHasNoBorders
📸 FIBROTARGET is LIVE at #ECM2026 in Copenhagen!
Coordinator Gianluca Matteoli and Bram Verstockt (KU Leuven) are presenting ongoing work in intestinal fibrosis and engaging with the ECM research community.
Learn more about the FIBROTARGET project here➡️https://loom.ly/IGYRLgM
📚Discover the FIBROTARGET Training Academy: a new resource designed to support learning on intestinal fibrosis in IBD!
Three modules are now available, offering insights into key concepts, current challenges, and emerging approaches in fibrosis research.
💻Learn more: https://loom.ly/wj313Io
📌 ICYMI: FIBROTARGET has released Training Academy – Module 2, focusing on in vivo fibrosis models for IBD research. Practical insights for early‑career researchers working on intestinal fibrosis 🔬
Explore the Training Academy here ➡️ https://loom.ly/wj313Io
#WorldIBDDay highlights the need for timely, equitable care.
Early diagnosis in #IBD remains a challenge, affecting progression and outcomes. FIBROTARGET coordinator Gianluca Matteoli explains how research supports earlier detection, better tools and patient involvement.
📹 Watch the interview ⤵️
🔊This week! FIBROTARGET joins the GENEGUT Cluster Event on RNA therapeutics for IBD (24 June), alongside EU projects, researchers, industry and patient groups to discuss key challenges and strengthen collaboration.
Explore the VR exhibition here➡️https://loom.ly/XRPsM
#HorizonEurope
📣 This #WorldIBDDay2026, FIBROTARGET supported the global campaign on access to IBD care, highlighting ongoing gaps in diagnosis, treatment and support.
➡️ Explore FIBROTARGET's contribution here: https://loom.ly/Y5rDUNA
#WorldIBDDay2026 #IBDHasNoBorders #HorizonEU
🟣🗺️ Today is #WorldIBDDay
IBD Has No Borders. Access to care should not depend on geography.
We support IFCCA’s call for equitable, timely IBD care worldwide and highlight the need to prevent complications like fibrosis.
Learn more➡️: https://loom.ly/cVlk6EQ
#IBDHasNoBorders
🔍Looking inside the gut: imaging tools to understand IBD fibrosis
🔬New non‑invasive imaging approaches aim to strengthen how fibrosis is detected, helping clinicians make clearer, more consistent decisions.
➡️Learn more and read the full article here: https://loom.ly/Qxk3wL4
#IBDHasNoBorders
Video
Video
Biomarkers are molecules found within the body that can signal the presence, progression, or severity of a disease or condition. Biomarkers associated with IBD Fibrosis could improve standard of care for patients through early detection and better disease monitoring.
